Key points are not available for this paper at this time.
SUMMARY Interferon reduced the production of virus neuraminidase during single-cycle growth of A2/HK/1/68 or recombinant X7(F1) influenza viruses in chicken embryo cell cultures. Neuraminidase activity, measurable within 6 h after infection, was reduced as much as 70 to 80% below control levels in interferon-treated cultures. X7(F1) neuraminidase yield was at least as sensitive a measure of interferon inhibition as vesicular stomatitis virus in the standard plaque-reduction assay. Interferon titre, expressed as the 30% neuraminidase reduction dose or NRD30, is derived from semi-logarithmic sigmoidal dose—response curves. The advantages that recommend the neuraminidase reduction bioassay for interferon assay include the precision of the enzyme assay (±1.0%), the precision of measurement of replicate samples of interferon (±9%), the reproducibility of interferon titres obtained sequentially (±20%), as well as the rapidity and economy of the method.
Sedmak et al. (Mon,) studied this question.